{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:22:01Z","timestamp":1792632121437,"version":"4.5.0"},"reference-count":31,"publisher":"Japanese Circulation Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2025,3,25]]},"DOI":"10.1253\/circj.cj-24-0801","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T22:12:35Z","timestamp":1738879955000},"page":"442-449","source":"Crossref","is-referenced-by-count":4,"title":["Impact of High-Sensitivity Cardiac Troponin T on Clinical Outcomes in Patients With Cardiac Sarcoidosis"],"prefix":"10.1253","volume":"89","author":[{"given":"Yoichi","family":"Takaya","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Nishii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazufumi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Yuasa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Newman LS, Rose CS, Maier LA. Sarcoidosis. <i>N Engl J Med<\/i> 1997; 336: 1224\u20131234.","DOI":"10.1056\/NEJM199704243361706"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoidosis: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. <i>Circulation<\/i> 1978; 58: 1204\u20131211.","DOI":"10.1161\/01.CIR.58.6.1204"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yazaki Y, Isobe M, Hiramitsu S, Morimoto M, Hiroe M, Omichi C, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. <i>Am J Cardiol<\/i> 1998; 82: 537\u2013540.","DOI":"10.1016\/S0002-9149(98)00377-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Takaya Y, Kusano K, Nishii N, Nakamura K, Ito H. Early and frequent defibrillator discharge in patients with cardiac sarcoidosis compared with patients with idiopathic dilated cardiomyopathy. <i>Int J Cardiol<\/i> 2017; 240: 302\u2013306.","DOI":"10.1016\/j.ijcard.2017.04.044"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. <i>Am J Cardiol<\/i> 2001; 88: 1006\u20131010.","DOI":"10.1016\/S0002-9149(01)01978-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chiu CZ, Nakatani S, Zhang G, Tachibana T, Ohmori F, Yamagishi M, et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. <i>Am J Cardiol<\/i> 2005; 95: 143\u2013146.","DOI":"10.1016\/j.amjcard.2004.08.083"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kusano K, Ishibashi K, Noda T, Nakajima K, Nakasuka K, Terasaki S, et al. Prognosis and outcomes of clinically diagnosed cardiac sarcoidosis without positive endomyocardial biopsy findings. <i>JACC Asia<\/i> 2021; 1: 385\u2013395.","DOI":"10.1016\/j.jacasi.2021.09.005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, et al. Detection of myocardial damage in patients with sarcoidosis. <i>Circulation<\/i> 2009; 120: 1969\u20131977.","DOI":"10.1161\/CIRCULATIONAHA.109.851352"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kataoka S, Yagishita D, Yazaki K, Kanai M, Hasegawa S, Shoda M, et al. Prolonged T-peak to T-end interval predicts implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. <i>Circ J<\/i> 2023; 87: 1058\u20131067.","DOI":"10.1253\/circj.CJ-23-0058"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Baba Y, Kubo T, Litaoka H, Okawa M, Yamanaka S, Kawada Y, et al. Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis. <i>Int Heart J<\/i> 2012; 53: 287\u2013292.","DOI":"10.1536\/ihj.53.287"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kandolin R, Lehtnen J, Airaksinen J, Vihinen T, Miettinen H, Kaikkonen K, et al. Usefulness of cardiac troponin as markers of early treatment response in cardiac sarcoidosis. <i>Am J Cardiol<\/i> 2015; 116: 960\u2013964.","DOI":"10.1016\/j.amjcard.2015.06.021"},{"key":"12","unstructured":"12. Hiraga H, Yuwai K, Hiroe M. Guideline for the diagnosis of cardiac sarcoidosis: Study report on diffuse pulmonary disease. <i>Jpn Ministry Health Welfare<\/i> 1993: 23\u201324 (in Japanese)."},{"key":"13","unstructured":"13. Japanese Ministry of Health and Welfare. Diagnostic standard and guidelines for sarcoidosis. <i>Jpn J Sarcoid Granulomatous Disord<\/i> 2007; 27: 89\u2013102."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 Guideline on diagnosis and treatment of cardiac sarcoidosis: Digest version. <i>Circ J<\/i> 2019; 83: 2329\u20132388.","DOI":"10.1253\/circj.CJ-19-0508"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Takaya Y, Nakamura K, Nishii N, Ito H. Clinical outcomes of patients with isolated cardiac sarcoidosis confirmed by clinical diagnostic criteria. <i>Int J Cardiol<\/i> 2021; 345: 49\u201353.","DOI":"10.1016\/j.ijcard.2021.10.150"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. De Bortoli A, Birnie DH. Diagnosis and treatment of cardiac sarcoidosis. <i>Circ J<\/i> 2023; 87: 471\u2013480.","DOI":"10.1253\/circj.CJ-22-0671"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Banba K, Kusano KF, Nakamura K, Morita H, Ogawa A, Ohtsuka F, et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. <i>Heart Rhythm<\/i> 2007; 4: 1292\u20131299.","DOI":"10.1016\/j.hrthm.2007.06.006"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Padala SK, Peaslee S, Sidhu MS, Steckman DA, Judson MA. Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis. <i>Int J Cardiol<\/i> 2017; 227: 565\u2013570.","DOI":"10.1016\/j.ijcard.2016.10.101"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Takaya Y, Kusano KF, Nakamura K, Ito H. Comparison of outcomes in patients with probable versus definite cardiac sarcoidosis. <i>Am J Cardiol<\/i> 2015; 115: 1293\u20131297.","DOI":"10.1016\/j.amjcard.2015.01.562"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sykora D, Bratcher M, Churchill R, Kim BM, Elwazir M, Young K, et al. Medical therapy and clinical outcomes in cardiac sarcoidosis patients with systolic heart failure. <i>Circ J<\/i> 2024; 89: 41\u201352.","DOI":"10.1253\/circj.CJ-24-0205"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nabeta T, Kitai T, Naruse Y, Taniguchi T, Yoshioka K, Tanaka H, et al. Risk stratification of patients with cardiac sarcoidosis: The ILLUMINATE-CS registry. <i>Eur Heart J<\/i> 2022; 43: 3450\u20133459.","DOI":"10.1093\/eurheartj\/ehac323"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Mehta D, Mori N, Goldbarg SH, Lubitz S, Wisnivesky JP, Teirstein A. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: Role of programmed ventricular stimulation. <i>Circ Arrhythm Electrophysiol<\/i> 2011; 4: 43\u201348.","DOI":"10.1161\/CIRCEP.110.958322"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Aimo A, Januzzi JL Jr, Vergaro G, Ripoli A, Latini R, Masson S, et al. Prognostic value of high-sensitivity troponin T in chronic heart failure: An individual patient data meta-analysis. <i>Circulation<\/i> 2018; 137: 286\u2013297.","DOI":"10.1161\/CIRCULATIONAHA.117.031560"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Latini R, Masson S, Anand IS, Missov E, Carlson M, Yago T, et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. <i>Circulation<\/i> 2007; 116: 1242\u20131249.","DOI":"10.1161\/CIRCULATIONAHA.106.655076"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Arima N, Ochi Y, Kubo T, Murakami Y, Nishino K, Yamamoto H, et al. Prospective multicenter screening with high-sensitivity cardiac troponin T for wild-type transthyretin cardiac amyloidosis in outpatient and community-based setting. <i>Circ J<\/i> 2024; 89: 24\u201330.","DOI":"10.1253\/circj.CJ-24-0479"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tanada Y, Sato Y, Sawa T, Fujiwara H, Takatsu Y. Serial measurement of high-sensitivity cardiac troponin I and N-terminal proB-type natriuretic peptide in a patient presenting with cardiac sarcoidosis. <i>Intern Med<\/i> 2012; 51: 3379\u20133381.","DOI":"10.2169\/internalmedicine.51.8334"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tashiro A, Tanaka Y, Hikita H, Takahashi A. High-sensitivity cardiac troponin serving as a useful marker for the early recognition of relapse of isolated cardiac sarcoidosis: A case report. <i>Eur Heart J Case Rep<\/i> 2022; 6: ytac116.","DOI":"10.1093\/ehjcr\/ytac116"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kiko T, Yoshihisa A, Kanno Y, Yokokawa T, Abe S, Miyata-Tatsumi M, et al. A multiple biomarker approach in patients with cardiac sarcoidosis. <i>Int Heart J<\/i> 2018; 59: 996\u20131001.","DOI":"10.1536\/ihj.17-695"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Troughton R, Michael Felker G, Januzzi JL Jr. Natriuretic peptide-guided heart failure management. <i>Eur Heart J<\/i> 2014; 35: 16\u201324.","DOI":"10.1093\/eurheartj\/eht463"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kamoshida J, Ueda N, Ishibashi K, Noda T, Kawabata T, Oka S, et al. Elevated B-type natriuretic peptide level as a residual risk factor for ventricular arrhythmias among patients undergoing cardiac resynchronization therapy with improved left ventricular ejection fraction. <i>Circ Rep<\/i> 2024; 6: 407\u2013414.","DOI":"10.1253\/circrep.CR-24-0065"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Yoshida S, Nakata T, Naya M, Momose M, Taniguchi Y, Fukushima Y, et al. Prognostic implications of sarcoidosis granulomas: Insights from the multicenter registry, the Japanese cardiac sarcoidosis prognostic study. <i>Circ Rep<\/i> 2023; 5: 252\u2013259.","DOI":"10.1253\/circrep.CR-23-0031"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/4\/89_CJ-24-0801\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T03:30:10Z","timestamp":1743219010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/4\/89_CJ-24-0801\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-24-0801","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"article-number":"CJ-24-0801"}}